Extremely significant positive changes in Catalyst Pharmaceutical Inc (NASDAQ: CPRX) investment behavior have recently occurred: the stock rose on very heavy volume, and its shorter term price trend turned up.
Recent notable positive changes in fundamentals have benefitted Catalyst Pharmaceutical Inc (NASDAQ: CPRX): the consensus estimate for December, 2026 increased significantly, and the consensus estimate for December, 2025 increased significantly.
In light of these very positive signals we are reviewing our current Overall Rating of A. We would continue to view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Catalyst Pharmaceutical has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Catalyst Pharmaceutical has a good Power Rating of 79 and a very high Appreciation Score of 88, with the Highest Value Trend Rating the result.
Recent Price Action
Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock closed at $24.23 on 3/21/25 after a large increase of 4.6%. Moreover, trading volume in this advance was exceptionally high at 386% of normal. The stock has risen 16.1% during the last week and has been exceptionally strong relative to the market over the last nine months.
Be the first to comment